Skip to main content

Ist das signalgemittelte EKG zur Kontrolle einer antiarrhythmischen Therapie geeignet?

  • Conference paper
Medikamentöse Behandlung des Postinfarktpatienten nach CAST

Zusammenfassung

Die nichtinvasive Kontrolle einer antiarrhythmischen Therapie wird anhand der Reduktion spontaner Arrhythmien im Langzeit-EKG durchgeführt. Probleme dieses Verfahrens liegen unter anderem in der ausgeprägten Spontanvariabilität der ventrikulären Arrhythmien und vor allem in dem fehlenden Nachweis, daß eine Reduktion dieser Ektopien den plötzlichen Herztod verhindert. Es wäre also von großem klinischen Nutzen, über eine weitere nichtinvasive Methode zur Einschätzung der Wirkung von Antiarrhythmika zu verfügen. Dabei bietet sich das Signalmittelungs-EKG an, da es mit der Beschreibung von Spätpotentialen den Nachweis von Zonen verzögerter Erregung ermöglicht, die eine Basis für kreisende Tachykardien darstellen können (9, 15, 16, 17, 35). Diese im Signalmittelungs-EKG erfaßbaren Spätpotentiale sind elektrische Signale, die nach Beendigung der normalen Kammererregung, also am Ende des QRS-Komplexes und in der folgenden ST-Strecke auftreten (2, 8, 35, 36), (Abb. 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abboud S, Beihassen B, Landiado S, Sadeh D (1983) Noninvasive recording of late ventricular activity using an advanced method in patients with a damaged mass of ventricular tissue. J Electrocardiol 16: 245

    Article  PubMed  CAS  Google Scholar 

  2. Berbari EJ, Lazzara R (1988) An introduction to high-resolution ECG recordings of cardiac late potentials. Arch Int Med 148: 1859

    Article  CAS  Google Scholar 

  3. Boineau JP, Cox JL (1973) Slow ventricular activation in acute myocardial infarction. A source of reentrant premature ventricular contractions. Circulation 48: 702

    PubMed  CAS  Google Scholar 

  4. Borbola J, Denes P (1988) Oral Amiodarone loading therapy. I The effect on serial signal-averaged elecrocardiographic recordings and the OTc in patients with ventricular tachyarrhythmias. Am Heart J 115: 1202

    Article  PubMed  CAS  Google Scholar 

  5. Borggrefe M, Karbenn U, Breithardt G (1982) Spätpotentiale und elektrophysiologische Befunde bei ventrikulären Tachykardien. Z Kardiol 71: 627

    Google Scholar 

  6. Breithardt G, Borggrefe M, Karbenn U, Schwarzmaier J (1988) Effects of pharmacological and non-pharmacological interventions on ventricular late potentials. Eur Heart J 8 (Suppl A): 97

    Google Scholar 

  7. Breithart G, Schwarzmaier J, Borggrefe M, Haerten K, Seipel L (1983) Prognostic significance of later ventricular potentials after acute myocardial infarction. Eur Heart J 4: 487

    Google Scholar 

  8. Breithart G, Schwarzmaier J, Karbenn U, Yeh HL, Seipel L (1982) Klinische Bedeutung nichtinvasiv registrierter ventrikulärer Spätpotentiale. Dtsch Med Wschr 107: 643

    Article  Google Scholar 

  9. Breithart G, Borggrefe M (1991) Pathophysiological mechanisms and clinical significance of ventricular late potentials, in press

    Google Scholar 

  10. Buckingham TA, Thessen CM, Hertweck D, Janosik DL, Kennedy HL (1989) Signal-averaged electrocardiography in the time and frequency domains. Am J Cardiol 63: 820

    Article  PubMed  CAS  Google Scholar 

  11. Cain ME, Ambos HD, Fischer AE, Markham J, Schechtman KB (1984) Non-invasive prediction of antiarrhythmic drug efficacy in patients with sustained ventricular tachycardia from frequency analysis of signal averaged ECGs. Circulation 70 (Suppl II): 252

    Google Scholar 

  12. Cain ME, Ambos HD, Witkowski FX, Sobel BE (1984) Fast-Fourier transform analysis of signalaveraged electrocardiograms for identification of patients prone to sustained ventricular tachycardia. Circulation 69: 711

    Article  PubMed  CAS  Google Scholar 

  13. De Langen CDJ, Spear JF, Levine JH, Moore EN (1985) The effect of procainamide on body surface late potentials and epicardial activation in infarcted dogs. Circulation 72 (Suppl III): 225

    Article  Google Scholar 

  14. Denniss AR, Ross DL, Cody DV, Ho B, Russell PA, Young AA (1984) Effect of antiarrhythmic therapy on delayed potentials in patients with ventricular tachycardia. JACC 3: 495

    Google Scholar 

  15. El-Sherif N, Turitto G, Fontaine JM (1988) Risk stratification of patients with complex ventricular arrhythmias. Herz 13: 204

    PubMed  CAS  Google Scholar 

  16. El-Sherif N, Gomes JA, Restivo M, Mehra R (1985) Late potentials and arrhythmogenesis. Pace 8, 440

    PubMed  CAS  Google Scholar 

  17. El-Sherif N, Mehry R, Gomes JAC, Kelen G (1983) Appraisal of a low noise electrocardiogram, J Am Coll Cardiol 1: 456

    Article  PubMed  CAS  Google Scholar 

  18. Fauchier JP, Cosnay P, Moquet B, Balleh H, Rouesnel PH (1988) Late ventricular potentials and spontaneous and induced entricular arrhythmias in dilated or hypertrophic cardiomyopathies. A prospective study about 83 patients. Pace 11: 1974

    PubMed  CAS  Google Scholar 

  19. Fenoglio JJ, Albala A, Silva FG, Friedmann PL, Wit AL (1976) Structural basis of ventricular arrhythmias in human myocardial infarction: a hypothesis. Hum-Pathol 7: 547

    Article  PubMed  Google Scholar 

  20. Gallagher JD, Fernandez J, Maranhao V, Gessman LJ (1986) Simultaneous Appearance of Endocardial Late Potentials and Ability to Induce Sustained Ventricular Tachycardia After Procainamide Administration. J Electrocard 19: 197–202

    Article  CAS  Google Scholar 

  21. Gessman L, Gallagher J, Del Rossi A, Fernandez J, Strong M, Maranhao V (1983) Prolongation of late potentials by type I antiarrhythmic drugs coincident with inducibility of ventricular tachycardia. Circulation 68 (Suppl III): 173

    Article  Google Scholar 

  22. Goedel-Meinen L, Hofmann M, Schmidt G, Maier-Rudolph W, Barthel P, Schrag A, Baedeker W, Blömer H (1990) Amiodarone and late potentials during long-term therapy. Clin Pharmacol Ther Tox 28: 449

    CAS  Google Scholar 

  23. Goedel-Meinen L, Schmidt G, Hofmann M, Jahns G, Klein G, Baedeker W, Blömer H (1986) Spätpotentiale vor und während akuter Testung von Klasse-I-Antiarrhythmika. Z Kardiol 75 (Suppl 4): 45

    Google Scholar 

  24. Haberl R, Jilge G, Pulter R, Steinbeck G (1988) Comparison of frequency and time domain analysis of the signal-averaged electrocardiogram in patients with ventricular tachycardia and coronary heart disease: methodologic validation and clinical relevance. JACC 12: 150

    PubMed  CAS  Google Scholar 

  25. Hombach V, Höpp HW, Braun V, Behrenbeck DW, Tauchert M, Hilger HH (1980) Die Bedeutung von Nachpotentialen innerhalb des ST-Segments im Oberflächen-EKG bei Patienten mit koronarer Herzkrankheit. Dtsch Med Wschr 105: 145

    Article  Google Scholar 

  26. Höpp HW, Deutsch H, Hombach V, Braun V, Hilger HH (1982) Medikamentöse Beeinflußbarkeit ventrikulärer Spätpotentiale. Z Kardiol 71: 206

    Google Scholar 

  27. Jauernig RA, Senges J, Lengfelder W, Rizos I, Hoffmann E, Brachmann J, Kübler W (1983) Effect of antiarrhythmic drugs on ventricular late potentials at sinus rhythm and at constant heart rate. In: Steinbach K, Glogar D, Laszkovics A, Scheiblhofer W, Weber H (eds) Cardiac Pacing. Steinkopff, Darmstadt, pp 773–778

    Google Scholar 

  28. Kidwell GA, Greenspon AJ, Decaro M, Volosin KJ, Jefferies L (1987) Use of the signalaveraged electrocardiogram to predict antiarrhythmic drug effect on sustained ventricular tachycardia. Circulation 76 (Suppl IV): 344

    Google Scholar 

  29. Naito M, Michelson EL, Kmetzo JJ, Kaplinsky E, Dreifus LS (1981) Failure of antiarrhythmic drugs to affect epicardial delay during acute experimental coronary artery occlusion and reperfusion: correlation with lack of antiarrhythmic efficacy. J Pharmacol exper Ther 218, 475–480

    CAS  Google Scholar 

  30. Oeff M (1987) Einzelschlagregistrierung verspäteter ventrikulärer Depolarisationen und ihre Frequenzanalyse mit der Fast-Fourier-Transformation. Methodische Aspekte. In: Steinbeck G (ed) Lebensbedrohliche ventrikuläre Herzrhythmusstörungen. Fortschritte in Diagnostik und Therapie. Steinkopff, Darmstadt, S 129

    Chapter  Google Scholar 

  31. Patterson E, Gibson JK, Lucchesi BR (1982) Electrophysiologic actions of lidocaine in an canine model of chronic myocardial ischemic damage — arrhythmogenic actions of lidocaine. J Cardiovasc Pharm 4, 924–934

    Article  Google Scholar 

  32. Rozanski JJ, Mortara D, Myerburg RJ, Castellanos A (1981) Body surface detection of delayed depolarizations in patients with recurrent ventricular tachycardia and left ventricular aneurysm. Circulation 63: 1172

    Article  PubMed  CAS  Google Scholar 

  33. Simson MB, Falcone R, Kindwall E (1985) The signal averaged electrocardiogram does not predict antiarrhythmic drug success. Circulation 72 (Suppl III): 7

    Google Scholar 

  34. Simson MB, Waxman HL, Falcone R, Marcus NH, Josephson ME (1983) Wirkungen von Antiarrhythmika auf nichtinvasiv registrierte Spätpotentiale. In: Breithardt, Loogen (Hrsg) Neue Aspekte in der medikamentösen Behandlung von Tachyarrhythmien (Die Bedeutung von Amiodaron). Urban und Schwarzenberg, München, S 86–93

    Google Scholar 

  35. Simson MB, Euler D, Michelson EL, Falcone RA, Spear JF, Moore NE (1981) Detection of delayed ventricular activation on the body surface in dogs. Am Physiol 241: 363

    Google Scholar 

  36. Simson MB (1981) Use of signals in the terminal QRS-complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 64: 235

    Article  PubMed  CAS  Google Scholar 

  37. Steinberg JS, Freedman RA (1987) The signal averaged ECG does not predict drug efficacy in sustained ventricular arrhythmias. Circulation 76 (Suppl IV): 344

    Article  Google Scholar 

  38. Vaughan-Williams EM (1970) Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Oelsen KH, Astra ABJ (eds) Symposion on Cardiac Arrhythmias. Södertälje, Sweden, pp 449–472

    Google Scholar 

  39. Zipes DP, Elharrar V, Noble RJ, Gaum WE, Troup PJ, Fasola A (1977) Effects of various drugs on ventricular conduction delay and ventricular arrhythmias during myocardial ischaemia in the dog. In: HE Kulbertus, Re-entrant Arrhythmias. Mechanisms and Treatment. Lancaster, pp 312–326

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Goedel-Meinen, L., Hofmann, M., Schmidt, G., Barthel, P., Baedeker, W., Blömer, H. (1991). Ist das signalgemittelte EKG zur Kontrolle einer antiarrhythmischen Therapie geeignet?. In: Schmidt, G. (eds) Medikamentöse Behandlung des Postinfarktpatienten nach CAST. Steinkopff. https://doi.org/10.1007/978-3-642-85414-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85414-9_8

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85415-6

  • Online ISBN: 978-3-642-85414-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics